Literature DB >> 9666084

Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain.

J M Kokoshka1, R R Metzger, D G Wilkins, J W Gibb, G R Hanson, A E Fleckenstein.   

Abstract

Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [3H]serotonin ([3H]5HT) and [3H]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [3H]5HT transport; an effect attributable to a decrease in Vmax. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [3H]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666084     DOI: 10.1016/s0006-8993(98)00472-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.

Authors:  Pei-Wen Chu; Gregory C Hadlock; Paula Vieira-Brock; Kristen Stout; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2010-08-25       Impact factor: 5.372

2.  Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval.

Authors:  Erin E Morgan; Steven P Woods; Amelia J Poquette; Ofilio Vigil; Robert K Heaton; Igor Grant
Journal:  Aust N Z J Psychiatry       Date:  2012-02       Impact factor: 5.744

3.  Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice.

Authors:  Jian-Hui Liang; Keng Wang; Hong-Lei Sun; Rong Han
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

Review 4.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

5.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

6.  Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.

Authors:  Christopher L German; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2012-08-23       Impact factor: 5.372

7.  Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.

Authors:  V Sandoval; E L Riddle; Y V Ugarte; G R Hanson; A E Fleckenstein
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

8.  Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.

Authors:  Charles V Vorhees; Elizabeth He; Matthew R Skelton; Devon L Graham; Tori L Schaefer; Curtis E Grace; Amanda A Braun; Robyn Amos-Kroohs; Michael T Williams
Journal:  Synapse       Date:  2010-10-08       Impact factor: 2.562

Review 9.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

10.  The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.

Authors:  Seth D Norrholm; David B Horton; Linda P Dwoskin
Journal:  Neuropharmacology       Date:  2007-10-07       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.